Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immediate Initiation of ART During Acute HIV Infection
NCT02656511Phase 4Active, not recruiting
- Sponsor
- University of California, San Francisco
- Start
- Dec 2015
- Primary completion
- May 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dolutegravir, emtricitabine, tenofovir alafenamide in human immunodeficiency virus infection (HIV), sponsored by University of California, San Francisco. Started Dec 2015; status: active, not recruiting.
02
Drugs
dolutegraviremtricitabinetenofovir alafenamide
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02656511.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02656511.